Impact of glycated hemoglobin (HbA1c) on outcomes in differentiated thyroid cancer with type 2 diabetes mellitus
Poor glycemic control, rather than T2DM itself, was linked to suboptimal treatment response. HbA1c may serve as a simple prognostic marker in diabetic patients with DTC.
Authors
- Merve Çatak (ORCID: https://orcid.org/0000-0003-2654-3911)
- Asım Kocabay (ORCID: https://orcid.org/0000-0003-0465-0783)
- Zeynep Çetin (ORCID: https://orcid.org/0000-0001-7824-4644)
- Özden Özdemir Başer (ORCID: https://orcid.org/0000-0001-8368-3182)
Institutions
- Tokai University (JP)
- Dokuz Eylül University (TR)
- Tokat Gaziosmanpaşa Üniversitesi (TR)
- State Hospital (GB)
- Amasya Üniversitesi (TR)
Publication Details
- Journal
- Endokrynologia Polska
- Published
- 2025-09-25
- DOI
- https://doi.org/10.5603/ep.107896
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00